AVANTI - Avelox® in Acute Exacerbations of chroNic bronchiTIs
NCT00846911
·
clinicaltrials.gov ↗
COMPLETED
Status
2672
Enrollment
INDUSTRY
Sponsor class
Conditions
Bronchitis, Chronic
Interventions
DRUG:
Moxifloxacin (Avelox, BAY12-8039)
Sponsor
Bayer